Gifthealth Partners with United Digestive to boost patient access and procedure prep. Gifthealth has announced a strategic ...

Rogers, chief scientific officer at Coronado Research, she shares insights on the evolving landscape of pharmaceutical ...

Private equity investors GHO Capital Partners and Ampersand Capital Partners have announced a merger agreement for the ...

Abbisko’s small molecule drug pimicotinib has smashed the primary goal of a phase 3 trial for the treatment of tenosynovial ...

The Taiwanese biotech has launched a phase 1/2 trial to test its small molecule cancer therapy in children and young adults ...

Wegovy manufacturer Ascendis Pharma has been tasked with supporting the development of a once-monthly GLP-1 drug.

Innovative radiotherapy offers a precision treatment alternative.

Palomar Health Foundation ignites youth interest in healthcare with Middle School Medical Discoveries program.

Scemblix is the first drug to show superiority over all standard of care therapies for a rare type of leukemia.

Clinical trial results have revealed that semaglutide treatment significantly reduced hospital admissions in overweight and ...

Advances in medicinal chemistry are driving the development of more sophisticated compounds, often with highly targeted mechanisms of action. These innovations, while promising, are also pushing the ...